Cargando…

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT

Detalles Bibliográficos
Autores principales:	Albiol, Nil, Lynton-Pons, Elionor, Aso, Olga, Moga, Esther, Gómez-Pérez, Lucía, Alejandre-Santiago, Jose, Triquell, Mercè, Roch, Nerea, Lázaro, Elisabeth, González, Iria, López-Contreras, Joaquín, Sanfeliu, Albert Esquirol, Sierra, Jorge, Martino, Rodrigo, Cadenas, Irene Garcia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430380/ http://dx.doi.org/10.1097/01.HS9.0000973012.02223.51

Ejemplares similares

mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
por: Albiol, Nil, et al.
Publicado: (2023)

mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
por: Moga, Esther, et al.
Publicado: (2022)

Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
por: Reyes-Leiva, David, et al.
Publicado: (2022)

(1197) Guillain-Barré Syndrome after Mrna-1273 Covid-19 Vaccine Booster in an Immunosuppressed Double Lung Transplant Recipient
por: Sindu, D., et al.
Publicado: (2023)

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation
por: Martino, Rodrigo, et al.
Publicado: (2021)

Acute Pericarditis Post mRNA-1273 COVID Vaccine Booster
por: Singh, Arminder, et al.
Publicado: (2022)

Immune Thrombocytopenia Following Booster Dose of the Moderna mRNA-1273 Vaccine
por: Breetz, Katherine A, et al.
Publicado: (2022)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
por: Cuadrado, Antonio, et al.
Publicado: (2022)

1534. A Quality Improvement Initiative for HIV Prevention in Underserved Communities
por: Clement, Meredith E, et al.
Publicado: (2023)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
por: Doria-Rose, Nicole A., et al.
Publicado: (2021)

Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
por: Pérez-Flores, Isabel, et al.
Publicado: (2023)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
por: Parés-Badell, Oleguer, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
por: Esquirol, Albert, et al.
Publicado: (2021)

A new knockdown resistance (kdr) mutation, F1534L, in the voltage-gated sodium channel of Aedes aegypti, co-occurring with F1534C, S989P and V1016G
por: Kushwah, Raja Babu S., et al.
Publicado: (2020)

1534 Missed Opportunities for HIV Diagnosis in a New Orleans Area Health System
por: Downing, Asia, et al.
Publicado: (2014)

1534. Gonorrhea Testing and Ceftriaxone Resistance in the Department of Veterans Affairs (VA), 2010-2019
por: Schirmer, Patricia, et al.
Publicado: (2020)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine
por: Mesina, Flordeluna Z.
Publicado: (2022)

Correction to: COVID arm that appeared in the contralateral upper extremity after mRNA‑1273 booster inoculation
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine
por: Marinelli, Tina, et al.
Publicado: (2021)

First report of the Phe1534Cys kdr mutation in natural populations of Aedes albopictus from Brazil
por: Aguirre-Obando, Oscar Alexander, et al.
Publicado: (2017)

High-Quality Reference Genome Sequence for the Oomycete Vegetable Pathogen Phytophthora capsici Strain LT1534
por: Stajich, Jason E., et al.
Publicado: (2021)

First detection of F1534C knockdown resistance mutation in Aedes aegypti (Diptera: Culicidae) from Cameroon
por: Yougang, Aurelie P., et al.
Publicado: (2020)

Evolution of kdr haplotypes in worldwide populations of Aedes aegypti: Independent origins of the F1534C kdr mutation
por: Cosme, Luciano Veiga, et al.
Publicado: (2020)

Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis
por: Karakizlis, Hristos, et al.
Publicado: (2022)

Serological response after COVID-19 mRNA-1273 booster dose in immunocompromised patients, Taiwan, July to August 2021
por: Lin, Kuan-Yin, et al.
Publicado: (2022)

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
por: Kim, Beop Chang, et al.
Publicado: (2022)

Association of 410L, 1016I and 1534C kdr mutations with pyrethroid resistance in Aedes aegypti from Ouagadougou, Burkina Faso, and development of a one-step multiplex PCR method for the simultaneous detection of 1534C and 1016I kdr mutations
por: Sombié, Aboubacar, et al.
Publicado: (2023)

Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
por: Gleeson, Sarah, et al.
Publicado: (2023)

The MDM2 309T>G Polymorphism and Ovarian Cancer Risk: A Meta-Analysis of 1534 Cases and 2211 Controls
por: Ma, Ying-Yu, et al.
Publicado: (2013)

Distribution and dissemination of the Val1016Ile and Phe1534Cys Kdr mutations in Aedes aegypti Brazilian natural populations
por: Linss, Jutta Gerlinde Birggitt, et al.
Publicado: (2014)

1534. Prevalence and Outcome of Neutropenic Enterocolitis Among Pediatric Acute Myeloid Leukemia Patients: A Developing Country Experience
por: Khedr, Reham, et al.
Publicado: (2018)

Retraction Note to: First report of the Phe1534Cys kdr mutation in natural populations of Aedes albopictus from Brazil
por: Aguirre-Obando, Oscar Alexander, et al.
Publicado: (2022)

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
por: Chu, Laurence, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jufableqraip6hc6pr3kmihgef